World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
110
Citations
44196
World Ranking
892
National Ranking
542

Medicine

D-Index
113
Citations
46851
World Ranking
4959
National Ranking
2690

Katherine K. Matthay publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Katherine K. Matthay sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 442 publications — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Katherine K. Matthay D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Katherine K. Matthay sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 113 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Katherine K. Matthay is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on Medicine, with significant contributions to Biochemistry, Genetics, and Molecular Biology. The main subfields of their work include Neurology, Cancer Research, Oncology, Genetics, and Surgery.

Their scientific output concentrates heavily on topics related to neuroblastoma and cancer, covering areas such as:

  • Neuroblastoma Research and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Lung Cancer Research Studies
  • Adrenal and Paraganglionic Tumors
  • Glioma Diagnosis and Treatment
  • Cancer therapeutics and mechanisms
  • Neuroendocrine Tumor Research Advances

Their recent publications reflect an active engagement with these topics and have appeared in a variety of scientific journals. Notable papers include:

  • Advancing therapy for neuroblastoma, 2022, Nature Reviews Clinical Oncology
  • Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032, 2021, Clinical Cancer Research
  • Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results, 2023, Nature Medicine
  • Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium, 2021, Journal of Clinical Oncology
  • 124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed Neuroblastoma, 2020, Journal of Nuclear Medicine

Katherine K. Matthay has published extensively in several scientific venues, with a notable number of publications in:

  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • Clinical Cancer Research
  • Cell Reports
  • Nature Reviews Clinical Oncology

Frequent collaborators in their research include Julie R. Park, Steven G. DuBois, Araz Marachelian, Meaghan Granger, and Arlene Naranjo. Their collaboration counts range from 12 to 25 coauthored papers, reflecting sustained research partnerships.

Best Publications

  • Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

    K K Matthay;J G Villablanca;R C Seeger;D O Stram

  • Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.

    D Papahadjopoulos;T M Allen;A Gabizon;E Mayhew

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

    Susan L. Cohn;Andrew D.J. Pearson;Wendy B. London;Tom Monclair

  • The International Neuroblastoma Pathology Classification (the Shimada system)

    Hiroyuki Shimada M.D.;Inge M. Ambros;Louis P. Dehner;Jun-ichi Hata

  • The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

    Tom Monclair;Garrett M. Brodeur;Peter F. Ambros;Hervé J. Brisse

  • Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    Katherine K. Matthay;C. Patrick Reynolds;Robert C. Seeger;Hiroyuki Shimada

  • Advances in Risk Classification and Treatment Strategies for Neuroblastoma

    Navin R. Pinto;Mark A. Applebaum;Samuel L. Volchenboum;Katherine K. Matthay

  • Molecular Biology of Neuroblastoma

    John M. Maris;Katherine K. Matthay

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    W.B. London;R.P. Castleberry;K.K. Matthay;A.T. Look

  • Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.

    Steven DuBois;Yan Kalika;John Lukens;Garrett Brodeur

  • Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project

    Hervé J. Brisse;M. Beth McCarville;Claudio Granata;K. Barbara Krug

  • Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes

    M.C. Woodle;K.K. Matthay;M.S. Newman;J.E. Hidayat

  • Retinoid therapy of high-risk neuroblastoma.

    C.Patrick Reynolds;Katherine K. Matthay;Judith G. Villablanca;Barry J. Maurer

  • The treatment of malignant pheochromocytoma with Iodine-131 metaiodobenzylguanidine (131I-MIBG): A comprehensive review of 116 reported patients

    Keh-Chuan Loh;P. A. Fitzgerald;K. K. Matthay;P. P. B. Yeo

  • International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

    Hiroyuki Shimada M.D.;Shunsuke Umehara;Yasumasa Monobe;Yoichi Hachitanda

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

  • Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.

    Michel Peuchmaur;Emanuele S. G. d'Amore;Vijay V. Joshi;Jun-ichi Hata

  • Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

    Wendy B. London;Victoria Castel;Tom Monclair;Peter F. Ambros

Frequent Co-Authors

John M. Maris
John M. Maris Children's Hospital of Philadelphia
Wendy B. London
Wendy B. London Harvard University
Susan L. Cohn
Susan L. Cohn University of Chicago
Robert C. Seeger
Robert C. Seeger Children's Hospital of Los Angeles
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Daniel O. Stram
Daniel O. Stram University of Southern California
Garrett M. Brodeur
Garrett M. Brodeur Children's Hospital of Philadelphia
Susan Groshen
Susan Groshen University of Southern California
C. Patrick Reynolds
C. Patrick Reynolds Texas Tech University Health Sciences Center
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While many students aspire to study Medicine in the USA, a variety of related online degrees offer rewarding career pathways in healthcare. If you are interested in the business side of healthcare, a health care administration online degree can prepare you for leadership roles in clinics, hospitals, and other medical settings.

For advanced opportunities, you may consider one of the most affordable online mha programs. These master's programs focus on high-level management skills and healthcare policy, making you eligible for top administrative positions.

If you’re already a practicing nurse aiming to advance your clinical expertise and leadership, exploring most affordable online dnp programs could be the next step. These programs let you earn a Doctor of Nursing Practice degree remotely, enhancing both patient care and career options.

Interested in pharmaceuticals? Online pharmacy school programs now make it possible to train as a Doctor of Pharmacy (PharmD) from home, providing flexibility for working professionals and students worldwide.

Best Scientists Citing Katherine K. Matthay

Trending Scientists

Recently Published Articles